Erica Palesandro

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio et al. · Molecular Cancer · 2017 · 69 citations · Full text

Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?

Fabrizio Carnevale‐Schianca, Susanna Gallo, Delia Rota‐Scalabrini et al. · Journal of Clinical Oncology · 2011 · 43 citations · Full text

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +6

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour

Lorenzo D’Ambrosio, Erica Palesandro, Paola Boccone et al. · European Journal of Cancer · 2017 · 37 citations

Surgical Oncology, Risk-based Follow-up, Cancer Risk +13

Alpha–fetoprotein elevation in NUT midline carcinoma: a case report

Lorenzo D’Ambrosio, Erica Palesandro, Marina Moretti et al. · BMC Cancer · 2017 · 19 citations · Full text

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta et al. · Journal of Translational Medicine · 2019 · 19 citations · Full text